Biotransformation Pathways and Metabolite Profiles of Oral [14C]Alisertib (MLN8237), an Investigational Aurora A Kinase Inhibitor, in Patients with Advanced Solid Tumors

Sandeepraj Pusalkar(Millennium Engineering and Integration (United States)), Swapan K. Chowdhury(Takeda (Japan))
Drug Metabolism and Disposition
January 8, 2020
Cited by 16


Related Papers

No related papers found

Powered by citation graph analysis